HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseli Lannes-Vieira Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

11/2014Levels of circulating anti-muscarinic and anti-adrenergic antibodies and their effect on cardiac arrhythmias and dysautonomia in murine models of Chagas disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseli Lannes-Vieira Research Topics

Disease

32Infections
04/2023 - 06/2004
23Chagas Disease (American Trypanosomiasis)
05/2024 - 02/2003
16Cardiomyopathies (Cardiomyopathy)
04/2023 - 06/2008
14Heart Diseases (Heart Disease)
01/2022 - 01/2014
9Inflammation (Inflammations)
11/2023 - 04/2003
8Myocarditis (Carditis)
10/2016 - 04/2003
7Fibrosis (Cirrhosis)
11/2023 - 12/2010
5Parasitemia
05/2024 - 05/2007
5Persistent Infection
01/2022 - 02/2010
5Heart Injuries
01/2020 - 01/2012
3Necrosis
01/2023 - 06/2014
3Neuroinflammatory Diseases
01/2023 - 01/2021
3Memory Disorders (Memory Loss)
01/2023 - 01/2021
3Toxoplasmosis
01/2022 - 03/2003
3Meningoencephalitis
10/2012 - 09/2003
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 12/2017
2Cysts
01/2022 - 01/2021
2Virus Diseases (Viral Diseases)
01/2021 - 01/2019
2Sinus Arrhythmia
01/2019 - 10/2016
2Shock
05/2007 - 02/2003
1Atrophy
01/2023
1Communicable Diseases (Infectious Diseases)
11/2022
1Hypoxia (Hypoxemia)
01/2022
1Chagas Cardiomyopathy
01/2021
1Bradycardia
01/2020
1Weight Loss (Weight Reduction)
12/2015
1Hypertrophy
03/2015

Drug/Important Bio-Agent (IBA)

11benzonidazole (benznidazole)IBA
05/2024 - 06/2008
10CytokinesIBA
01/2023 - 02/2003
6Interferon-gamma (Interferon, gamma)IBA
05/2018 - 04/2003
5Chemokine ReceptorsIBA
04/2021 - 04/2003
5VaccinesIBA
01/2021 - 02/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 06/2008
4MicroRNAs (MicroRNA)IBA
01/2023 - 01/2015
4Pentoxifylline (Trental)FDA LinkGeneric
01/2023 - 03/2015
3Proteins (Proteins, Gene)FDA Link
05/2023 - 02/2010
3Thomsen-Friedenreich antibodiesIBA
11/2022 - 09/2004
3Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2014
3CC ChemokinesIBA
01/2020 - 09/2004
3Met- RANTESIBA
01/2020 - 09/2004
3Messenger RNA (mRNA)IBA
01/2020 - 03/2007
3Connexin 43 (Connexin43)IBA
01/2019 - 01/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016 - 01/2012
3PerforinIBA
01/2012 - 10/2009
2CollagenIBA
11/2023 - 12/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 01/2022
2trans-sialidaseIBA
05/2023 - 09/2009
2DNA (Deoxyribonucleic Acid)IBA
04/2023 - 08/2013
2Therapeutic UsesIBA
01/2022 - 01/2019
2Type I Tumor Necrosis Factor ReceptorsIBA
09/2017 - 06/2008
2Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
01/2017 - 10/2003
2Integrin alpha4beta1 (VLA-4)IBA
01/2017 - 10/2003
2Fibronectins (Fibronectin)IBA
03/2015 - 01/2014
2AntibodiesIBA
11/2014 - 09/2003
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2012 - 02/2010
2IsoenzymesIBA
01/2012 - 01/2012
2InterferonsIBA
10/2011 - 02/2010
2InterleukinsIBA
02/2010 - 02/2003
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2009 - 09/2009
2Cell Adhesion MoleculesIBA
07/2009 - 10/2003
2Chemokine CCL5IBA
03/2007 - 09/2004
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2004 - 10/2003
1Amiodarone (Amiodarona)FDA LinkGeneric
05/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2023
1Bevacizumab (Avastin)FDA Link
11/2023
1KininsIBA
04/2023
1Bradykinin B1 ReceptorIBA
04/2023
1ColchicineFDA LinkGeneric
11/2022
1Chloroquine (Aralen)FDA LinkGeneric
11/2022
1Drug CombinationsIBA
11/2022
1Sulfadiazine (Sulphadiazine)FDA Link
01/2022
1methylxanthineIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2022
1Pyrimethamine (Daraprim)FDA Link
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2022
1Chemotactic FactorsIBA
01/2021
1Sirolimus (Rapamycin)FDA Link
01/2021
1Interleukin-2 (IL2)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1CCR1 ReceptorsIBA
01/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020
1LigandsIBA
01/2019
14- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA
01/2019
1ChemokinesIBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2018
1NF-kappa B (NF-kB)IBA
12/2017
1Interleukin-6 (Interleukin 6)IBA
09/2017
1IntegrinsIBA
01/2017
1tempolIBA
10/2016
1Metformin (Glucophage)FDA LinkGeneric
10/2016
1AntioxidantsIBA
10/2016
1ResveratrolIBA
10/2016
1SandIBA
12/2015

Therapy/Procedure

14Therapeutics
05/2024 - 07/2009
1Investigational Therapies (Experimental Therapy)
10/2016
1Combination Drug Therapy (Combination Chemotherapy)
01/2016